Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2017/09/009864
CTRI/2017/09/009864
Completed
Phase 2

Comparison of outcomes of weekly Paclitaxel versus weekly Cisplatin in Oral cavity, Oropharyngeal and Hypopharyngeal cancer patients with concurrent Radiation - A Randomized Controlled Trial.

Jawaharlal Institute of Post Graduate Medical Education and Research0 sites54 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Jawaharlal Institute of Post Graduate Medical Education and Research
Enrollment
54
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
May 29, 2019
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Jawaharlal Institute of Post Graduate Medical Education and Research

Eligibility Criteria

Inclusion Criteria

  • •1\.all biopsy proven oral cavity, oropharyngeal
  • •and hypopharyngeal cancer patients are taken
  • •2\.Normal liver function tests and normal
  • •hemogram reports
  • •3\.normal renal function tests should be there
  • •to include under the trial.
  • •4 performance score according to ECOG scale
  • •should be more than or equal to 2

Exclusion Criteria

  • •1\. patients with distant metastasis
  • •2\. patients with uncontrollable hypertension
  • •and diabetes.
  • •3\. history of previous oncological surgery for
  • •the same condition
  • •4\. history of previous irradiation to the same

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
A study of low intensity chemotherapy in relapsed and refractory lymphoma patientsHealth Condition 1: C817- Other Hodgkin lymphomaHealth Condition 2: C858- Other specified types of non-Hodgkin lymphoma
CTRI/2020/08/026992Jawaharlal Institute Post Graduate Medical Education and Research
Not yet recruiting
Phase 3
A study to compare weekly Paclitaxel injection with best supportive care in patients with lung cancerHealth Condition 1: null- Patients with small cell lung cancer relapsed on two or more lines of chemotherapy
CTRI/2018/04/013507Tata Memorial Hospital
Completed
Phase 2
Assessment of efficacy of weekly paclitaxel chemotherapy in ovarian cancersAdvanced Ovarian Cancer.Malignant neoplasm of ovary
IRCT2017050333789N1Taleghani Hospital- Shahid Beheshti University of Medical Sciences14
Not yet recruiting
Phase 2
ow dose cancer drugs for advanced stomach cancerHealth Condition 1: C169- Malignant neoplasm of stomach, unspecified
CTRI/2022/11/047033JIPMER PONDICHERRY
Active, not recruiting
Not Applicable
Weekly maintainance therapy with Paclitaxel vs control arm after first line chemotherapy in patients with metastatic breast carcinoma. Phase III multicentric clinical trial.
EUCTR2004-004031-59-ITAZIENDA OSPEDALIERA POLICLINICO DI MODENA